HBS Healthcare Alumni Annual Conference
November 6 & 7, 2014
Healthcare is a
dynamic industry, where new technologies, providers, regulations, and trends continually
join the marketplace. One thing remains constant - the need to be
connected to people, information, organizations, and education.
This year’s conference
will bring together individuals who are not only industry leaders but are
changing the very nature of the business of healthcare.
* Regina E Herzlinger, PhD
Nancy R McPherson
Professor of Business Administration, Harvard Business School
* Michael Dal Bello, MBA 2002
Partner, Pritzker Group
* Brad Fleugel
President & Chief Strategy Officer, Walgreens
* Jim Foreman
Director for Exchange Solutions, Towers Watson
* Gary L Gottlieb, MD, MBA
CEO, Partners HealthCare
* John Kelliher
Director, Marwood Group
* Joe Kveder, MD
Director, Partners Center for Connected Health
* Matthew Levin
Executive Vice President
& Head of Global Strategy, Aon Corporation
* View the
Boom or Bust? Lean in or Pull Back?
Long or Short?
From the Castlight IPO to David
Einhorn calling athenahealth a "bubble stock", there's been major
activity in the healthcare markets during 2014. Looking ahead, the experts all
have different opinions as to where venture, private equity, and public markets
are headed. One observation is for sure -- there's money to be made. Join us as
our panel of experts discusses where the markets are headed and what you should
be doing to be prepared. Be sure to bring your smartphone, iPad, or laptop, as
you'll be voicing your opinions throughout the session via real-time polling.
Industry Focused Tracks
Emerging Business Opportunity or Passing Fancy?
While much of the public debate over healthcare
today relates to the Affordable Care Act and the snafus around public
exchanges, many insiders are more optimistic about the growth opportunities
of private health insurance exchanges, web-based "marketplaces"
that allow an employer to continue to provide health care benefits but both
limit their financial exposure and get them out of the business of managing
these benefits. Spurred on by large
employers like Sears, Darden and most recently Walgreen's adopting private
exchanges, many are anticipating significant movement, and accordingly a
number of entrepreneurs and established companies have sought to create
offerings ahead of what they see as growing market demand. Join us as we hear from those who have created
exchanges as well as companies that have already made the choice to migrate
to these new channels.
Convergence of Healthcare Devices and Genomics
As technology races ahead, clinicians and
business leaders struggle to catch up.
What clinical developments are unfolding from advances in digital
health and social media in the wild.
And what business models are gaining traction?
Models for Drug Development
Several negative trends have been impacting drug
development over the last decade. The cost and duration of drug development
has increased, while the probability of success has decreased in many
indications. This, in part, drove venture investors away from investing in
high-risk, early-stage innovation.
Meanwhile, the return on investment of in-house biopharma R&D has
been steadily declining. This has forced these companies to look externally
for pipeline assets through their BD and corporate venture groups. Biopharma
companies have also been increasingly investing upstream in early-stage
research, going so far as to partner directly with universities. In this
session, we endeavor to explore new models of identifying, funding, and
developing innovative science.
The Affordable Care Act:
What’s Done, What’s Coming & What
You Need to Know
Patient Protection and Affordable Care Act (aka Obamacare) represents the
most significant regulatory overhaul of the US healthcare system since the
passage of Medicare and Medicaid. The ACA was enacted with the goals of
increasing the quality, availability, and affordability of healthcare in the
US. What has already been
implemented? What are the next
significant milestones on the horizon? What could be the impact if the
Republicans take control of the Senate in November? Are there continuing opportunities for
the popular conference sessions, Roundtable Discussions, get executives swapping valuable ideas and experiences on some
of the most important issues facing the business of healthcare. They are being held Friday, November 7 over
breakfast, from 7:15-8:30 am.
are interested in hosting a Roundtable, please submit your discussion topic to email@example.com. Leaders are eligible for a discounted
is the primary reason alumni attend year after year. At this year's conference we
will again be creating an Attendee Directory (with photos), badges indicating
industry affiliation, and a message board to schedule on-the-fly meetings all
to make it easier to identify important healthcare connections with fellow
November 6 & 7, 2014
One Bennett Street
Early Bird rates through September 23.
Special rates at
The Charles are available for a limited time or until our block is fulfilled.
For more information on becoming
an HBSHAA Sponsor, please contact